<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36613170</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>02</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Prevalence and Associated Factors of Post-COVID-19 Syndrome in a Brazilian Cohort after 3 and 6 Months of Hospital Discharge.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">848</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph20010848</ELocationID><Abstract><AbstractText>(1) Objectives: To evaluate the frequency and factors associated with the Post-COVID-19 Syndrome (PCS) in COVID-19 survivors after 3 and 6 months of hospital discharge; (2) Methods: We conducted a cohort study with patients who were hospitalized with COVID-19 in a referral public hospital in Bras&#xed;lia, Federal District, Brazil. After 3 and 6 months of discharge, patients answered a questionnaire about PCS symptoms. Poisson regression with robust variance was used to estimate the crude and adjusted prevalence ratios (PR and aPR) of PCS. (3) Results: The prevalence of PCS was 81% and 61% after 3 and 6 months of hospital discharge, respectively. The main symptoms after 3 months of discharge were hair loss (44%), fatigue (42%), and memory loss (39%); while after 6 months, they were memory loss (29%) and fatigue (27%). In the multivariate analysis, the main factor associated with PCS was female gender (aPR): 1.28 (1.16-1.41) and 1.60 (1.34-1.90), 3 and 6 months after hospital discharge, respectively. Hypercholesterolemia was also associated with PCS after 3 months aPR of 1.15 (1.04-1.27). After 6 months of discharge, obesity [aPR: 1.22 (1.03-1.45)] and pronation [aPR: 1.15 (1.06-1.25)] were relevant associated factors. (4) Conclusions: The prevalence of PCS was high in COVID-19 survivors who had the moderate and severe forms of the disease. Memory loss was the most persistent symptom. Our data pointed to female gender, hypercholesterolemia, obesity, and pronation during hospitalization as relevant PCS-associated risk factors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lapa</LastName><ForeName>Juliana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>N&#xfa;cleo de Medicina Tropical, Faculdade de Medicina, Universidade de Bras&#xed;lia, Campus Universit&#xe1;rio Darcy Ribeiro, Asa Norte, Bras&#xed;lia 70910-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosa</LastName><ForeName>Davi</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-5418-0153</Identifier><AffiliationInfo><Affiliation>N&#xfa;cleo de Medicina Tropical, Faculdade de Medicina, Universidade de Bras&#xed;lia, Campus Universit&#xe1;rio Darcy Ribeiro, Asa Norte, Bras&#xed;lia 70910-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendes</LastName><ForeName>Jo&#xe3;o Pedro Lima</ForeName><Initials>JPL</Initials><AffiliationInfo><Affiliation>N&#xfa;cleo de Medicina Tropical, Faculdade de Medicina, Universidade de Bras&#xed;lia, Campus Universit&#xe1;rio Darcy Ribeiro, Asa Norte, Bras&#xed;lia 70910-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deusdar&#xe1;</LastName><ForeName>Rodolfo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1343-3265</Identifier><AffiliationInfo><Affiliation>N&#xfa;cleo de Medicina Tropical, Faculdade de Medicina, Universidade de Bras&#xed;lia, Campus Universit&#xe1;rio Darcy Ribeiro, Asa Norte, Bras&#xed;lia 70910-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Gustavo Adolfo Sierra</ForeName><Initials>GAS</Initials><Identifier Source="ORCID">0000-0003-1425-926X</Identifier><AffiliationInfo><Affiliation>N&#xfa;cleo de Medicina Tropical, Faculdade de Medicina, Universidade de Bras&#xed;lia, Campus Universit&#xe1;rio Darcy Ribeiro, Asa Norte, Bras&#xed;lia 70910-900, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Avalia&#xe7;&#xe3;o de Tecnologia em Sa&#xfa;de, Ramiro Barcelos Street, 2350, Santa Cec&#xed;lia, Porto Alegre, RS, Bras&#xed;lia 90035-903, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006937" MajorTopicYN="Y">Hypercholesterolemia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006779" MajorTopicYN="N">Hospitals, Public</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>8</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36613170</ArticleId><ArticleId IdType="pmc">PMC9820092</ArticleId><ArticleId IdType="doi">10.3390/ijerph20010848</ArticleId><ArticleId IdType="pii">ijerph20010848</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pneumonia of Unknown Cause&#x2014;China.  [(accessed on 1 September 2022)].  Available online:  https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON229.</Citation></Reference><Reference><Citation>Coronav&#xed;rus: Brasil Confirma Primeiro Caso Da Doen&#xe7;a&#x2014;Not&#xed;cia&#x2014;UNA-SUS.  [(accessed on 7 December 2022)]; Available online:  https://www.unasus.gov.br/noticia/coronavirus-brasil-confirma-primeiro-caso-da-doenca.</Citation></Reference><Reference><Citation>COVID-19 Map&#x2014;Johns Hopkins Coronavirus Resource Center.  [(accessed on 16 March 2021)].  Available online:  https://coronavirus.jhu.edu/map.html.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (Great Britain)  COVID-19 Rapid Guideline.  [(accessed on 26 May 2022)];2020  Available online:  http://www.ncbi.nlm.nih.gov/books/NBK567261/</Citation></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. E Clin. Med. 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J., Liu Y., Zhang J., Xu Y., Dong W. Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clin. Microbiol. Infect. 2020;27:89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>The Writing Committee for the COMEBAC Study Group. Morin L., Savale L., Pham T., Colle R., Figueiredo S., Harrois A., Gasnier M., Lecoq A.-L., Meyrignac O., et al. Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. JAMA. 2021;325:1525. doi: 10.1001/jama.2021.3331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L., Drake T.M., Pauley E., Jesudason E.C., Olliaro P., Lim W.S., Gillesen A., Berry C., Lowe D.J., McPeake J., et al. Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg. Health Eur. 2021;8:100186. doi: 10.1016/j.lanepe.2021.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Antonelli M., Canas L.S., Molteni E., et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., McAuley H., Harrison E.M., Shikotra A., Singapuri A., Sereno M., Elneima O., Docherty A.B., I Lone N., Leavy O.C., et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): A UK multicentre, prospective cohort study. Lancet Respir. Med. 2021;9:1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Rose E.B., Shapiro N.I., Files D.C., Gibbs K.W., Erickson H.L., Steingrub J.S., Smithline H.A., et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network&#x2014;United States, March&#x2013;June 2020. MMWR. Morb. Mortal. Wkly. Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dowds J., O&#x2019;Brien K., Sheill G., Dyer A.H., O&#x2019;Kelly B., Hynes J.P., Mooney A., Dunne J., Cheallaigh C.N., et al. Persistent Poor Health Post-COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity. Annals ATS. 2021;18:997&#x2013;1003. doi: 10.1513/AnnalsATS.202009-1175OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202009-1175OC</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>de Miranda D.A.P., Gomes S.V.C., Filgueiras P.S., Corsini C.A., Almeida N.B.F., Silva R.A., Medeiros M.L., Vilela R.V.R., Fernandes G.R., Grenfell R.F.Q. Long COVID-19 syndrome: A 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil. Trans. R. Soc. Trop. Med. Hyg. 2022;116:1007&#x2013;1014. doi: 10.1093/trstmh/trac030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/trstmh/trac030</ArticleId><ArticleId IdType="pubmed">35514142</ArticleId></ArticleIdList></Reference><Reference><Citation>Minist&#xe9;rio da Sa&#xfa;de. Secretaria de Vigil&#xe2;ncia em Sa&#xfa;de . Guia de Vigil&#xe2;ncia Epidemiol&#xf3;gica&#x2014;Emerg&#xea;ncia de Sa&#xfa;de P&#xfa;blica DE Import&#xe2;ncia Nacional Pela Doen&#xe7;a Pelo Coronav&#xed;rus 2019. Volume 2. Minist&#xe9;rio da Sa&#xfa;de; Brasilia, Brazil: 2021. p. 88.</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Florencio L.L., Cuadrado M.L., Plaza-Manzano G., Navarro-Santana M. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Intern. Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira J.F., de &#xc1;vila R.E., de Oliveira N.R., da Cunha Severino Sampaio N., Botelho M., Gon&#xe7;alves F.A., Neto C.J.F., de Almeida Milagres A.C., Gomes T.C.C., Pereira T.L., et al. Persistent symptoms, quality of life, and risk factors in long COVID: A cross-sectional study of hospitalized patients in Brazil. Int. J. Infect. Dis. 2022;122:1044&#x2013;1051. doi: 10.1016/j.ijid.2022.07.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.07.063</ArticleId><ArticleId IdType="pmc">PMC9330427</ArticleId><ArticleId IdType="pubmed">35908724</ArticleId></ArticleIdList></Reference><Reference><Citation>Titze-de-Almeida R., Thaylise R da C., Dias dos Santos Silva L., Santos Ferreira C., Pena Silva C. Persistent, new-onset symptoms and mental health complaints in Long COVID in a Brazilian cohort of non-hospitalized patients. Proc. Natl. Acad. Sci. USA. 2021;118:e2024358118. doi: 10.1186/s12879-022-07065-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07065-3</ArticleId><ArticleId IdType="pmc">PMC8821794</ArticleId><ArticleId IdType="pubmed">35135496</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M.S., Kristiansen M.F., Hanusson K.D., Danielsen M.E., Steig B., Gaini S., Str&#xf8;m M., Weihe P. Long COVID in the Faroe Islands: A Longitudinal Study Among Nonhospitalized Patients. Clin. Infect. Dis. 2020;73:e4058&#x2013;e4063. doi: 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng F., Dai C., Cai P., Wang J., Xu L., Li J., Hu G., Wang Z., Zheng F., Wang L. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex. J. Med Virol. 2020;92:2050&#x2013;2054. doi: 10.1002/jmv.25989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25989</ArticleId><ArticleId IdType="pmc">PMC7267228</ArticleId><ArticleId IdType="pubmed">32383183</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T., Ellingson M.K., Wong P., Israelow B., Lucas C., Klein J., Silva J., Mao T., Oh J.E., Tokuyama M., et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588:315&#x2013;320. doi: 10.1038/s41586-020-2700-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2700-3</ArticleId><ArticleId IdType="pmc">PMC7725931</ArticleId><ArticleId IdType="pubmed">32846427</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff M.C., Ramonell R.P., Haddad N.S., Anam F.A., Rudolph M.E., Walker T.A., Truong A.D.., Dixit A.N.., Han J.E.., Cabrera-Mora M., et al. Dysregulated naive B cells and de novo autoreactivity in severe COVID-19. Nature. 2022;611:139&#x2013;147. doi: 10.1038/s41586-022-05273-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05273-0</ArticleId><ArticleId IdType="pmc">PMC9630115</ArticleId><ArticleId IdType="pubmed">36044993</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Prins J.B., van der Meer J.W., Bleijenberg G. Chronic fatigue syndrome. Lancet. 2006;367:346&#x2013;355. doi: 10.1016/S0140-6736(06)68073-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)68073-2</ArticleId><ArticleId IdType="pubmed">16443043</ArticleId></ArticleIdList></Reference><Reference><Citation>Meini S., Suardi L.R., Busoni M., Roberts A.T., Fortini A. Olfactory and gustatory dysfunctions in 100 patients hospitalized for COVID-19: Sex differences and recovery time in real-life. Eur. Arch. Oto-Rhino-Laryngology. 2020;277:3519&#x2013;3523. doi: 10.1007/s00405-020-06102-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06102-8</ArticleId><ArticleId IdType="pmc">PMC7271634</ArticleId><ArticleId IdType="pubmed">32500326</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes Paranhos A.C., Nazareth Dias &#xc1;.R., Machado da Silva L.C., Vieira Hennemann Koury G., de Jesus Sousa E., Cerasi A.J., Souza G.S., Quaresma J.A.S., Falc&#xe3;o L.F.M. Sociodemographic Characteristics and Comorbidities of Patients With Long COVID and Persistent Olfactory Dysfunction. JAMA Netw Open. 2022;5:e2230637. doi: 10.1001/jamanetworkopen.2022.30637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.30637</ArticleId><ArticleId IdType="pmc">PMC9459661</ArticleId><ArticleId IdType="pubmed">36074464</ArticleId></ArticleIdList></Reference><Reference><Citation>Loosen S.H., Jensen B.-E.O., Tanislav C., Luedde T., Roderburg C., Kostev K. Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: A cross-sectional study from 50,402 COVID-19 patients. Infection. 2022;50:1165&#x2013;1170. doi: 10.1007/s15010-022-01784-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01784-0</ArticleId><ArticleId IdType="pmc">PMC8966865</ArticleId><ArticleId IdType="pubmed">35355237</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Torres-Macho J., Elvira-Mart&#xed;nez C.M., Molina-Trigueros L.J., Sebasti&#xe1;n-Viana T., Hern&#xe1;ndez-Barrera V. Obesity is associated with a greater number of long-term post-COVID symptoms and poor sleep quality: A multicentre case-control study.  [(accessed on 8 December 2022)];Int. J. Clin. Pract. 2021 75 doi: 10.1111/ijcp.14917. Available online:  https://onlinelibrary.wiley.com/doi/10.1111/ijcp.14917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14917</ArticleId><ArticleId IdType="doi">10.1111/ijcp.14917</ArticleId><ArticleId IdType="pmc">PMC8646300</ArticleId><ArticleId IdType="pubmed">34569684</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke R.W., Lumeng C.N. Pathways to Severe COVID-19 for People with Obesity. Obesity. 2020;29:645&#x2013;653. doi: 10.1002/oby.23099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.23099</ArticleId><ArticleId IdType="pmc">PMC7753541</ArticleId><ArticleId IdType="pubmed">33270351</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell M.L., Catalfamo C.J., Farland L.V., Ernst K.C., Jacobs E.T., Klimentidis Y.C., Jehn M., Pogreba-Brown K. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT. PLoS ONE. 2021;16:e0254347. doi: 10.1371/journal.pone.0254347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254347</ArticleId><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., Houben-Wilke S., Burtin C., Posthuma R., Franssen F.M.E., et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome? ERJ Open Res. 2020;6:00542&#x2013;02020. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Minist&#xe9;rio da Sa&#xfa;de, Secretaria de Ci&#xea;ncia, Tecnologia, Inova&#xe7;&#xe3;o e Insumos Estrat&#xe9;gicos em Sa&#xfa;de . Informe Semanal n&#xb0; 01 de Evid&#xea;ncias sobre Variantes de Aten&#xe7;&#xe3;o de SARS-CoV-2. Minist&#xe9;rio da Sa&#xfa;de; Bras&#xed;lia, Brazil: 2021.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>